Copyright © 2007, European Society of Cardiology
Biochemistry of protein tyrosine nitration in cardiovascular pathology
Departamento de Bioquímica and Center for Free Radical and Biomedical Research, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
* Corresponding author. Departamento de Bioquímica, Facultad de Medicina, Avda. Gral. Flores 2125 11800, Montevideo, Uruguay. Tel.: +598 2 924 9561; fax: +598 2 924 9563. rradi{at}fmed.edu.uy
Several pathologies of the cardiovascular system are associated with an augmented production of nitric oxide and/or superoxide-derived oxidants and/or alteration in the antioxidant detoxification pathways that lead to nitroxidative stress. One important consequence of these reactive intermediates at the biochemical level is the nitration of protein tyrosines, which is performed through either of two of the relevant nitration pathways that operate in vivo, namely peroxynitrite and heme peroxidase-dependent nitration. Proteins nitrated at tyrosine residues have been detected in several compartments of the cardiovascular system. In this review a selection of nitrated proteins in plasma (fibrinogen, plasmin, Apo-1), vessel wall (Apo-B, cyclooxygenase, prostaglandin synthase, Mn-superoxide dismutase) and myocardium (myofibrillar creatine kinase, 
-actinin, sarcoplasmic reticulum Ca2+ ATPase) are analyzed in the context of cardiovascular disease. Nitration of tyrosine can affect protein function, which could directly link nitroxidative stress to the molecular alterations found in disease. While some proteins are inactivated by nitration (e.g. Mn-SOD) others undergo a gain-of-function (e.g. fibrinogen) that can have an ample impact on the pathophysiology of the cardiovascular system. Nitrotyrosine is also emerging as a novel independent marker of cardiovascular disease. Pharmacological strategies directed towards inhibiting protein nitration will assist to shed light on the relevance of this post-translational modification to human cardiovascular pathology.
KEYWORDS Free radicals; Nitric oxide; Nitration; Nitroxidative stress; Nitrotyrosine; Peroxynitrite
1 The covalent substitution of a nitro (–NO2, +45 Da) moiety in either two of the ortho position carbon atoms (3-position) of the phenolic ring of a tyrosine residue gives rise to 3-nitrotyrosine. It is a posttranslational modification originated by nitric oxide-derived oxidants such as peroxynitrite and nitrogen dioxide (•NO2).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Peluffo, P. Calcerrada, L. Piacenza, N. Pizzano, and R. Radi Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1781 - H1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Abriata, A. Cassina, V. Tortora, M. Marin, J. M. Souza, L. Castro, A. J. Vila, and R. Radi Nitration of Solvent-exposed Tyrosine 74 on Cytochrome c Triggers Heme Iron-Methionine 80 Bond Disruption: NUCLEAR MAGNETIC RESONANCE AND OPTICAL SPECTROSCOPY STUDIES J. Biol. Chem., January 2, 2009; 284(1): 17 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Barreiro, R Rabinovich, J Marin-Corral, J A Barbera, J Gea, and J Roca Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD Thorax, January 1, 2009; 64(1): 13 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Piper, D. Garcia-Dorado, and E. A. Martinson Monitoring the success of articles: a look back and a look ahead Cardiovasc Res, December 1, 2008; 80(3): 321 - 323. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jun, V. Savransky, A. Nanayakkara, S. Bevans, J. Li, P. L. Smith, and V. Y. Polotsky Intermittent hypoxia has organ-specific effects on oxidative stress Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1274 - R1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Ikonomidis, J. P. Lekakis, M. Nikolaou, I. Paraskevaidis, I. Andreadou, T. Kaplanoglou, P. Katsimbri, G. Skarantavos, P. N. Soucacos, and D. T. Kremastinos Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis Circulation, May 20, 2008; 117(20): 2662 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cassina, A. Cassina, M. Pehar, R. Castellanos, M. Gandelman, A. de Leon, K. M. Robinson, R. P. Mason, J. S. Beckman, L. Barbeito, et al. Mitochondrial Dysfunction in SOD1G93A-Bearing Astrocytes Promotes Motor Neuron Degeneration: Prevention by Mitochondrial-Targeted Antioxidants J. Neurosci., April 16, 2008; 28(16): 4115 - 4122. [Abstract] [Full Text] [PDF]
|
|